10 February 2010
Novartis plans to assume complete control over Alcon Laboratories Inc. in a two-step process that some analysts and some members of Alcon?s board of directors are challenging for its fairness under Swiss and US merger laws.
 |
15 September 2009
The news broke at today's show that Alcon is to gain access to proprietary antibody fragment technology particularly suited to treat eye diseases with its plan to acquire ESBATech AG, a Swiss biotechnology firm. |
11 September 2009
The first European Master's degree in Clinical and Surgical Ophthalmology, a prestigious international project of advanced studies for ophthalmological professionals, was presented in Lugano (Switzerland) by the European School for Advanced Studies in Ophthalmology.
|
10 September 2009
$400 million in cash has secured the acquisition of Visiogen for Abbott and secured the latter a next-generation accommodating IOL technology to help presbyopia in cataract patients.
|
22 July 2009
Ronald Pitts Crick, the ophthalmologist who was behind the development of the operating microscope, has died aged 92.
|
22 July 2009
Professor Shahina Pardhan has been appointed director of Anglia Ruskin University's new Vision and Eye Research Unit (VERU).
|
15 July 2009
Ocular Therapeutics has signed non-disclosure agreements with two of the largest pharmaceutical firms in the world. The unnamed companies are interested in a new treatment approach in the largest of the ophthalmic markets.
|
17 June 2009
Dr Jayakrishna Ambati, professor and vice chairman of Ophthalmology and Visual Sciences at the University of Kentucky, has been chosen to receive the 2010 Cogan Award from The Association for Research in Vision and Opthalmology (ARVO).
|
03 June 2009
Colum Honan is to be Bausch & Lomb's general manager with responsibility for its Waterford plant which manufactures contact lenses and other eye health products.
|
| 
